Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

146,406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Sulfiredoxin inhibitor induces preferential death of cancer cells through reactive oxygen species-mediated mitochondrial damage.
Kim H, Lee GR, Kim J, Baek JY, Jo YJ, Hong SE, Kim SH, Lee J, Lee HI, Park SK, Kim HM, Lee HJ, Chang TS, Rhee SG, Lee JS, Jeong W. Kim H, et al. Among authors: lee js, lee gr, lee j, lee hi, lee hj. Free Radic Biol Med. 2016 Feb;91:264-74. doi: 10.1016/j.freeradbiomed.2015.12.023. Epub 2015 Dec 23. Free Radic Biol Med. 2016. PMID: 26721593
Skullcapflavone II inhibits osteoclastogenesis by regulating reactive oxygen species and attenuates the survival and resorption function of osteoclasts by modulating integrin signaling.
Lee J, Son HS, Lee HI, Lee GR, Jo YJ, Hong SE, Kim N, Kwon M, Kim NY, Kim HJ, Lee YJ, Seo EK, Jeong W. Lee J, et al. Among authors: lee gr, lee hi, lee yj. FASEB J. 2019 Feb;33(2):2026-2036. doi: 10.1096/fj.201800866RR. Epub 2018 Sep 14. FASEB J. 2019. PMID: 30216110
SFII has therapeutic potential in the treatment and prevention of bone diseases caused by excessive osteoclast activity.-Lee, J., Son, H. S., Lee, H. I., Lee, G.-R., Jo, Y.-J., Hong, S.-E., Kim, N., Kwon, M., Kim, N. Y., Kim, H. J., Le …
SFII has therapeutic potential in the treatment and prevention of bone diseases caused by excessive osteoclast activity.-Lee, J …
Dehydrocostus lactone suppresses osteoclast differentiation by regulating NFATc1 and inhibits osteoclast activation through modulating migration and lysosome function.
Lee HI, Lee J, Hwang D, Lee GR, Kim N, Kwon M, Lee H, Piao D, Kim HJ, Kim NY, Kim HS, Seo EK, Kang D, Jeong W. Lee HI, et al. Among authors: lee h, lee gr, lee j. FASEB J. 2019 Aug;33(8):9685-9694. doi: 10.1096/fj.201900862R. Epub 2019 May 30. FASEB J. 2019. PMID: 31145860
These results indicate that DL has therapeutic potential to treat bone diseases caused by excessive or hyperactive osteoclasts.-Lee, H. I., Lee, J., Hwang, D., Lee, G.-R., Kim, N., Kwon, M., Lee, H., Piao, D., Kim, H. J., Kim, N. Y., Kim, …
These results indicate that DL has therapeutic potential to treat bone diseases caused by excessive or hyperactive osteoclasts.-Lee, …
146,406 results
You have reached the last available page of results. Please see the User Guide for more information.